Research and Markets: TreatmentTrends: European Gout Study 2011

DUBLIN--(BUSINESS WIRE)-- Research and Markets ( has announced the addition of Decision Resources, Inc's new report "TreatmentTrends®: European Gout Study 2011" to their offering.

TreatmentTrends® Gout in the EU is a report that covers the use of uric acid lowering (UAL) therapies as well as gout flare remedies for the treatment and management of gout among rheumatologists and primary care physicians in the E5 countries. The report focuses on current and future use of agents, patient market share, perceived strengths and weaknesses of the key UAL products, barriers to broader usage, promotional efforts and is heavy on therapies in development.

Key Topics Covered:

Background, Methods, and Objectives

  • Key Findings
  • Respondent Demographics
  • Current Treatment Algorithms: Chronic UAL Therapy
  • Current Treatment Algorithms: Acute Gout Therapy

Perceptions of UAL Product Performance

  • Promotional Messaging

Future Trends

Evaluation of Krystexxa

Products in Development

For more information visit

Source: Decision Resources, Inc

Research and Markets
Laura Wood, Senior Manager.
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices, Pharmaceuticals

Source: Research and Markets